Search the Newsreel

Inogen Launches Voxi 5 Stationary Oxygen Concentrator

Inogen Inc. has launched the Voxi 5, a new stationary oxygen concentrator (SOC) developed with Yuwell Medical, to expand access to oxygen therapy for long-term care patients in the US. This device provides 1-5 liters per minute of continuous flow oxygen, offering a compact …

Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut

Inogen (INGN) reported breakeven earnings for Q2 2026, surpassing estimates, with revenues rising 3% year-over-year to $95.1 million, driven by strong international demand and new products. Despite this, the company cut its full-year 2026 revenue guidance to $355-$361 million, down from previous estimates, due …

Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67

Inogen, Inc. (NASDAQ:INGN) reported quarterly results last week, with revenues of US$95m matching predictions and statutory losses coming in 8.7% smaller than expected at US$0.14 per share. Following the report, analysts reconfirmed their loss per share estimates for next year but downgraded revenue estimates, …

Arrowstreet Capital Limited Partnership Acquires 393,310 Shares of Inogen, Inc $INGN

Arrowstreet Capital Limited Partnership significantly increased its stake in Inogen, Inc. by 203.9% in the first quarter, purchasing 393,310 additional shares, bringing its total holdings to 586,159 shares. This makes Arrowstreet Capital own 2.16% of the medical technology company, with institutional investors collectively holding …

Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Inogen (NASDAQ:INGN) reported quarterly earnings, beating expectations with a loss of $0.14 per share against a projected $0.15 loss. While revenue slightly missed estimates at $95.08 million, the company showed improved profitability with a 15% rise in adjusted EBITDA and strong international sales growth. …

Inogen (INGN) Has a New Rating from B. Riley Securities

B. Riley Securities initiated coverage on Inogen (INGN) with a Buy rating and a $14.00 price target, following Needham's Buy rating and $12.00 price target for the stock. Inogen reported a quarterly revenue of $95.08 million and a GAAP net loss of $3.85 million …

Inogen Inc Q2 2026: Revenue $95.08M, EPS $(0.14) — 10-Q Summary

Inogen Inc. reported Q2 2026 revenue of $95.08M and diluted EPS of $(0.14), marking modest top-line growth and improved margins. The company's net loss narrowed to $3.85M from $4.15M a year prior, driven by higher unit volumes and favorable foreign exchange, particularly in international …

Inogen (INGN) Stock Drops As Guidance Cut Clouds Margin Progress

Inogen, Inc. (INGN) Stock Price, News, Quote & History

This Yahoo Finance page provides detailed financial information for Inogen, Inc. (INGN), a medical technology company specializing in respiratory health products. It includes real-time stock quotes, historical data, key financial metrics, performance overview, earnings trends, analyst insights, and comparison tools with similar companies in …

Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong International Growth and New ...

Inogen Inc. (INGN) reported strong international revenue growth of 15% year-over-year and core POC unit volume growth of over 12% in Q2 2026, with new products Voxy and Aurora gaining traction. Despite these positive indicators and an expanded gross margin, the company lowered its …

Inogen, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:INGN) 2026-08-06

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) reported a Q2 loss of $0.14 per share, which was better than the Zacks Consensus Estimate of a $0.17 loss, and also surpassed revenue estimates with $95.08 million. Despite underperforming the S&P 500 year-to-date, the company's stock currently holds a Zacks Rank …

Inogen Inc earnings beat by $0.03, revenue topped estimates

Inogen Inc (NASDAQ: INGN) reported its second-quarter earnings, beating analyst EPS estimates by $0.03 with an EPS of $-0.14. The company also surpassed revenue expectations, bringing in $95.1M against a consensus estimate of $95.05M. Despite the beat, the stock has seen a -7.83% decline …

Beijing Jingneng Clean Energy Warns of 25%–35% Profit Drop in First Half 2026

Beijing Jingneng Clean Energy Co., Limited Provides Earnings Guidance for the Six Months Ended 30 June 2026

Inogen (INGN) to Announce Earnings on Thursday

Inogen, Inc Revenue Breakdown – NASDAQ:INGN

Inogen, Inc. (NASDAQ: INGN) generated $348.67 million USD in revenue last year. The primary driver of this revenue was the Oxygen Concentrators and Related Accessories segment, contributing $295.30 million USD. Geographically, the United States was the largest contributor to the company's revenue, accounting for …

Inogen Inc (INGN) Cash Flow

This article provides a detailed cash flow statement for Inogen Inc (INGN), outlining quarterly and annual data for operating, investing, and financing activities. It includes key financial metrics such as net income, capital expenditures, and free cash flow, along with year-over-year percentage changes. The …

Inogen Inc (INGN) Income Statement

This article provides a detailed quarterly and annual income statement for Inogen Inc (INGN), outlining key financial metrics such as total revenue, cost of revenue, operating expenses, and net income. It also includes an FAQ section to help users understand how to interpret these …

Inogen Inc (INGN) Institutional Confidence

Inogen Inc (INGN) has an institutional shareholding score of 7.00, placing it 79th in the Healthcare Equipment & Supplies industry. Institutional investors hold 75.89% of shares, a 4.39% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, with 2.35% of outstanding shares.

Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Inogen Inc (INGN), detailing its current valuation score, market capitalization, and P/E ratio. As of July 24, 2026, the company's valuation score is 8.91, placing it 58th in the Healthcare Equipment & Supplies industry. The article notes …

INGN|Inogen Inc|Price:6.310|Chg%:+0.160

This article provides a comprehensive stock analysis of Inogen Inc (INGN), highlighting its relatively healthy fundamentals, high growth potential, and current valuation as "fairly valued" within the Healthcare Equipment & Supplies industry. Despite recent weak stock market performance, the company exhibits strong fundamentals and …

Inogen to report Q2 2026 results after market close, host conference call

Inogen (NASDAQ: INGN) has scheduled the release of its second-quarter 2026 financial results for August 6, 2026, after the market closes. The company will also host an earnings call on the same day at 2 p.m. PT (5 p.m. ET), with a webcast available …

Inogen to report second quarter 2026 results on August 6

Inogen will release its second quarter 2026 financial results after market close on Thursday, August 6, 2026. The medical technology company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its performance. Investors can access the live webcast …